Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Flisiak

Showing results (1-10 of 372) with videos related to

Pageof 38
Sort By:
Przeglad Epidemiologiczny|April 6, 2005
[Chance of hepatic fibrosis treatment in chronic hepatitis C]Robert Flisiak
Clinical and Experimental Hepatology|September 1, 2017
Meeting of Initiative Group for Central European Hepatologic Collaboration (CEHC): Warsaw, 19-21 November 2015Robert Flisiak
Annals of Parasitology|August 29, 2014
Lyme borreliosisTomasz Szulżyk, Robert Flisiak
Antiviral Therapy|June 7, 2018
Correction: Quantitative measurement of HCV core antigen for management of interferon-free therapy in HCV-infected patientsMariusz Łucejko, Robert Flisiak
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2013
Metabolic syndrome and hepatitis C infection--brothers in armsJerzy Jaroszewicz, Robert Flisiak
Expert Opinion on Biological Therapy|September 11, 2010
Albinterferon-alpha 2b: a new treatment option for hepatitis CRobert Flisiak, Iwona Flisiak
Przeglad Epidemiologiczny|June 10, 2008
[Treatment recommendations of chronic hepatitis B. Did the world escape us?]Robert Flisiak, Jerzy Jaroszewicz
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|April 3, 2004
[Therapeutic vaccination in chronic hepatitis B: chance or utopia?]Robert Flisiak, Danuta Prokopowicz
Przeglad Epidemiologiczny|June 10, 2008
[Diagnostics and treatment of Lyme borreliosis. Recommendations of Polish Society of Epidemiology and Infectious Diseases]Robert Flisiak, Sławomir Pancewicz,
Antiviral Therapy|October 11, 2017
Quantitative measurement of HCV core antigen for management of interferon-free therapy in HCV-infected patientsMariusz Łucejko, Robert Flisiak
Pageof 38

Showing results (1-10 of 372) with videos related to

Sort By:
Pageof 38
Przeglad Epidemiologiczny|April 6, 2005
[Chance of hepatic fibrosis treatment in chronic hepatitis C]Robert Flisiak
Clinical and Experimental Hepatology|September 1, 2017
Meeting of Initiative Group for Central European Hepatologic Collaboration (CEHC): Warsaw, 19-21 November 2015Robert Flisiak
Annals of Parasitology|August 29, 2014
Lyme borreliosisTomasz Szulżyk, Robert Flisiak
Antiviral Therapy|June 7, 2018
Correction: Quantitative measurement of HCV core antigen for management of interferon-free therapy in HCV-infected patientsMariusz Łucejko, Robert Flisiak
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2013
Metabolic syndrome and hepatitis C infection--brothers in armsJerzy Jaroszewicz, Robert Flisiak
Expert Opinion on Biological Therapy|September 11, 2010
Albinterferon-alpha 2b: a new treatment option for hepatitis CRobert Flisiak, Iwona Flisiak
Przeglad Epidemiologiczny|June 10, 2008
[Treatment recommendations of chronic hepatitis B. Did the world escape us?]Robert Flisiak, Jerzy Jaroszewicz
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|April 3, 2004
[Therapeutic vaccination in chronic hepatitis B: chance or utopia?]Robert Flisiak, Danuta Prokopowicz
Przeglad Epidemiologiczny|June 10, 2008
[Diagnostics and treatment of Lyme borreliosis. Recommendations of Polish Society of Epidemiology and Infectious Diseases]Robert Flisiak, Sławomir Pancewicz,
Antiviral Therapy|October 11, 2017
Quantitative measurement of HCV core antigen for management of interferon-free therapy in HCV-infected patientsMariusz Łucejko, Robert Flisiak
Pageof 38